Following on from our recent article, Why Real-World Evidence? (which can be found here). This week we take a look at the what data is available for medical research. We hope this will be a useful framework to utilise when trying to decide how best to answer your questions. The next obvious step is to try and work out how to answer them. The simplest way of doing this is to work out what variables you need to test your question, decide on a rough budget, and then consider the options. From my point of view, I find the most effective prism for this assessment comes as the Four Domains of data (see below) which includes all data types and sources possible.
CK Aspire are delighted to have been named a finalist in the EyeforPharma Most Valuable Patient Initiative category in collaboration with GSK on the Salford Lung Study.
We are attending Evidence Europe at the Victoria Park Plaza in London on the 22-23rd of February. For those of you who have not come across the Evidence series of conferences, they are one of the worlds premier Real-World Evidence conferences featuring many thought leaders from across the industry.
In a recent edition of ‘Trends’ entitled ‘Real-World Evidence Revolution’, Paul Simms (Chairman of eyeforpharma) articulated a thought I have had running through my head for a while now:
“… the health economy is changing fast, moving from measuring inputs (e.g. number of patients seen, pills sold ect.) to outputs (most importantly, patient outcomes).”
A recent publication in ‘Pharmacoepidemiology and Safety’ highlighted how our team of Safety Nurses worked in conjunction with a remote EHR monitoring system to ensure patient safety throughout the Salford Lung Study.
CK Aspire’s Domiciliary Research Team were thrilled to attend the Nursing Times Awards last night at the Grosvenor House Hotel, Park Lane in London.
Today the London Stock Exchange have announced the 2016 edition of their 1000 Companies to Inspire Britain report. CK Group are thrilled to have been identified and included in the publication. The report is a celebration of the UK’s fastest-growing and most dynamic small and medium sized businesses.
CK Aspire are pleased to announce they are exhibiting at the upcoming 26th International Congress of the European Respiratory Society in London between 3rd and 7th September at stand C.25.
CK Aspire submitted an entry into the Nursing Times Awards for our Domiciliary Research Team involved in the Salford Lung Study earlier this year. The short list has been announced and it’s fantastic to say that their entry has been shortlisted in the clinical research nursing category.
Salford Lung Study results show COPD patients treated with Relvar® Ellipta® achieve superior reduction in exacerbations compared with ‘usual care’
Pioneering GSK study provides important new data on the effectiveness of Relvar Ellipta (FF/VI) when used in everyday clinical practice